- Recommendation ID
- IPG805/1
- Question
Further evidence generation and research should be in the form of suitably powered randomised controlled trials or patient registries across all risk categories. The trials should report details of:
- Any explanatory notes
(if applicable) -
patient selection
-
comparisons between TAVI and SAVR or medical treatment
-
comparisons between different TAVI prosthetic aortic valves
-
long-term outcomes, including:
-
valve durability and reintervention rates
-
the need for a second TAVI valve-in-valve implantation
-
-
safety outcomes, including embolisation, stroke and myocardial infarction.
-
Source guidance details
- Comes from guidance
- Transcatheter aortic valve implantation (TAVI) for native aortic valve regurgitation
- Number
- IPG805
- Date issued
- June 2025
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 10/07/2025 |